Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Shining a Light on the Dark Side.
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase.
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
Designing Dose-Finding Phase I Clinical Trials: Top Questions That Should Be Discussed With Your Clinical Pharmacologist.
Coronavirus Disease 2019-Associated PICU Admissions: A Report From the Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study Registry.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
A novel calpain inhibitor for treatment of transient retinal ischemia in the rat.
One or more keywords matched the following properties of
A novel calpain inhibitor for treatment of transient retinal ischemia in the rat.
Property
Value
has major subject area list
Calpain; Ischemia; Leupeptins; Retinal Diseases; Retinal Vessels
Search Criteria
Retinal Diseases